In letter to Makary, biotech CEOs push for FDA stability and say volatility threatens US innovation
21st November 2025 Uncategorised 0Hundreds of industry leaders have signed a letter to FDA Director Marty Makary, M.D., about the importance of having a predictable regulatory agency, citing a survey in which 82% of biopharma respondents said they were concerned about the FDA’s ability to function.
More: In letter to Makary, biotech CEOs push for FDA stability and say volatility threatens US innovation
Source: fierce